Efficacy Study of Early Presumptive Therapy (EPT) for Deep Fungal Infection

We retrospectively studied the efficacy of early presumptive therapy (EPT). Subjects and Method: Of the critically ill patients admitted from January 1998 to the end of December 2000 to Kyorin University Trauma Burn and Intensive Care Center, 77 cases were diagnosed with suspected deep fungal infect...

Full description

Saved in:
Bibliographic Details
Published inNihon Ishinkin Gakkai zasshi Vol. 45; no. 4; pp. 203 - 208
Main Authors Shimazaki, Syuji, Goto, Hideaki, Yoshizawa, Mie, Sakaki, Seiki, Tanaka, Hideharu, Yoshinari, Kiyoshi
Format Journal Article
LanguageEnglish
Japanese
Published Japan The Japanese Society for Medical Mycology 2004
Subjects
Online AccessGet full text
ISSN0916-4804
1882-0476
DOI10.3314/jjmm.45.203

Cover

Abstract We retrospectively studied the efficacy of early presumptive therapy (EPT). Subjects and Method: Of the critically ill patients admitted from January 1998 to the end of December 2000 to Kyorin University Trauma Burn and Intensive Care Center, 77 cases were diagnosed with suspected deep fungal infection, and EPT was administered. The diagnosis of suspected deep fungal infection was made by definition. EPT (FLCZ 200 to 400mg/day×14 days) was started as soon as the diagnosis was made and continued for two weeks. Its efficacy was retrospectively studied by analyzing the clinical findings, changes in local organisms, and hematological tests. Results: After treatment, 62% of the patients showed improvement in clinical signs of infection, elimination of locally detected fungus, and improvement in the serum diagnosis test. Post-EPT detection levels of the fungus had decreased to 21%. The mean pre-EPT body temperature was 38.7°C±0.6°C, but the mean post-EPT temperature was 36.7°C±0.6°C. The mean level of blood 1, 3-β-D-glucan was 35±13pg/ml at the time the diagnosis was made, but returned to normal levels after treatment had concluded. No patients died as a direct result of the fungal infection. Conclusion: This study of early presumptive therapy in critically ill patients in the emergency and intensive care medicine fields showed the therapy in these, and in high risk patients to be efficacious.
AbstractList We retrospectively studied the efficacy of early presumptive therapy (EPT). Of the critically ill patients admitted from January 1998 to the end of December 2000 to Kyorin University Trauma Burn and Intensive Care Center, 77 cases were diagnosed with suspected deep fungal infection, and EPT was administered. The diagnosis of suspected deep fungal infection was made by definition. EPT (FLCZ 200 to 400 mg/day x 14 days) was started as soon as the diagnosis was made and continued for two weeks. Its efficacy was retrospectively studied by analyzing the clinical findings, changes in local organisms, and hematological tests. After treatment, 62% of the patients showed improvement in clinical signs of infection, elimination of locally detected fungus, and improvement in the serum diagnosis test. Post-EPT detection levels of the fungus had decreased to 21%. The mean pre-EPT body temperature was 38.7 degrees C +/- 0.6 degrees C, but the mean post-EPT temperature was 36.7 degrees C +/- 0.6 degrees C. The mean level of blood 1,3-beta-D-glucan was 35 plus minus 13 pg/ml at the time the diagnosis was made, but returned to normal levels after treatment had concluded. No patients died as a direct result of the fungal infection. This study of early presumptive therapy in critically ill patients in the emergency and intensive care medicine fields showed the therapy in these, and in high risk patients to be efficacious.
We retrospectively studied the efficacy of early presumptive therapy (EPT).UNLABELLEDWe retrospectively studied the efficacy of early presumptive therapy (EPT).Of the critically ill patients admitted from January 1998 to the end of December 2000 to Kyorin University Trauma Burn and Intensive Care Center, 77 cases were diagnosed with suspected deep fungal infection, and EPT was administered. The diagnosis of suspected deep fungal infection was made by definition. EPT (FLCZ 200 to 400 mg/day x 14 days) was started as soon as the diagnosis was made and continued for two weeks. Its efficacy was retrospectively studied by analyzing the clinical findings, changes in local organisms, and hematological tests.SUBJECTS AND METHODOf the critically ill patients admitted from January 1998 to the end of December 2000 to Kyorin University Trauma Burn and Intensive Care Center, 77 cases were diagnosed with suspected deep fungal infection, and EPT was administered. The diagnosis of suspected deep fungal infection was made by definition. EPT (FLCZ 200 to 400 mg/day x 14 days) was started as soon as the diagnosis was made and continued for two weeks. Its efficacy was retrospectively studied by analyzing the clinical findings, changes in local organisms, and hematological tests.After treatment, 62% of the patients showed improvement in clinical signs of infection, elimination of locally detected fungus, and improvement in the serum diagnosis test. Post-EPT detection levels of the fungus had decreased to 21%. The mean pre-EPT body temperature was 38.7 degrees C +/- 0.6 degrees C, but the mean post-EPT temperature was 36.7 degrees C +/- 0.6 degrees C. The mean level of blood 1,3-beta-D-glucan was 35 plus minus 13 pg/ml at the time the diagnosis was made, but returned to normal levels after treatment had concluded. No patients died as a direct result of the fungal infection.RESULTSAfter treatment, 62% of the patients showed improvement in clinical signs of infection, elimination of locally detected fungus, and improvement in the serum diagnosis test. Post-EPT detection levels of the fungus had decreased to 21%. The mean pre-EPT body temperature was 38.7 degrees C +/- 0.6 degrees C, but the mean post-EPT temperature was 36.7 degrees C +/- 0.6 degrees C. The mean level of blood 1,3-beta-D-glucan was 35 plus minus 13 pg/ml at the time the diagnosis was made, but returned to normal levels after treatment had concluded. No patients died as a direct result of the fungal infection.This study of early presumptive therapy in critically ill patients in the emergency and intensive care medicine fields showed the therapy in these, and in high risk patients to be efficacious.CONCLUSIONThis study of early presumptive therapy in critically ill patients in the emergency and intensive care medicine fields showed the therapy in these, and in high risk patients to be efficacious.
We retrospectively studied the efficacy of early presumptive therapy (EPT). Subjects and Method: Of the critically ill patients admitted from January 1998 to the end of December 2000 to Kyorin University Trauma Burn and Intensive Care Center, 77 cases were diagnosed with suspected deep fungal infection, and EPT was administered. The diagnosis of suspected deep fungal infection was made by definition. EPT (FLCZ 200 to 400mg/day×14 days) was started as soon as the diagnosis was made and continued for two weeks. Its efficacy was retrospectively studied by analyzing the clinical findings, changes in local organisms, and hematological tests. Results: After treatment, 62% of the patients showed improvement in clinical signs of infection, elimination of locally detected fungus, and improvement in the serum diagnosis test. Post-EPT detection levels of the fungus had decreased to 21%. The mean pre-EPT body temperature was 38.7°C±0.6°C, but the mean post-EPT temperature was 36.7°C±0.6°C. The mean level of blood 1, 3-β-D-glucan was 35±13pg/ml at the time the diagnosis was made, but returned to normal levels after treatment had concluded. No patients died as a direct result of the fungal infection. Conclusion: This study of early presumptive therapy in critically ill patients in the emergency and intensive care medicine fields showed the therapy in these, and in high risk patients to be efficacious.
Author Yoshizawa, Mie
Shimazaki, Syuji
Goto, Hideaki
Tanaka, Hideharu
Sakaki, Seiki
Yoshinari, Kiyoshi
Author_xml – sequence: 1
  fullname: Shimazaki, Syuji
  organization: Department of Traumatology and Critical Care Medicine
– sequence: 1
  fullname: Goto, Hideaki
  organization: Department of Traumatology and Critical Care Medicine
– sequence: 1
  fullname: Yoshizawa, Mie
  organization: Laboratory Department, Kyorin University School of Medicine
– sequence: 1
  fullname: Sakaki, Seiki
  organization: Department of Traumatology and Critical Care Medicine
– sequence: 1
  fullname: Tanaka, Hideharu
  organization: Department of Traumatology and Critical Care Medicine
– sequence: 1
  fullname: Yoshinari, Kiyoshi
  organization: Department of Pharmacology and Toxicology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15550916$$D View this record in MEDLINE/PubMed
BookMark eNpt0M9LwzAUB_Agis7pybvkJIp0Jk3StEeZm4qCgvMcsuxFO_rLJBX639s63UG8JIf3-T5430O0W9UVIHRCyYQxyq_W67KccDGJCdtBI5qmcUS4THbRiGQ0iXhK-AE69H5NCIuZlPvogAohhuEIPcyszY02HX4J7arDtcUz7YoOPzvwbdmE_BPw4h2cbjp8PnteXGBbO3wD0OB5W73pAt9XFkzI6-oI7VldeDj--cfodT5bTO-ix6fb--n1Y2RYTEJkTCoJTVYmE0sr7IonMRUyJhaWhPPUxDoV0gIVmZaSaJOw2FJmCXCR2Gwp2BidbfY2rv5owQdV5t5AUegK6tarRJJUciZ7ePoD22UJK9W4vNSuU7_n94BugHG19w6sMnnQwy3B6bxQlKihYjVUrLhQfcV95vJPZrv2X32z0Wsf9BtsrXYhNwV8W5plZPB88_Sx7di8a6egYl_mypP9
CitedBy_id crossref_primary_10_5649_jjphcs_36_392
crossref_primary_10_1021_acsbiomaterials_9b00069
crossref_primary_10_3109_s10165_010_0287_5
crossref_primary_10_3314_jjmm_49_137
crossref_primary_10_3918_jsicm_14_519
ContentType Journal Article
Copyright The Japanese Society for Medical Mycology
Copyright_xml – notice: The Japanese Society for Medical Mycology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.3314/jjmm.45.203
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1882-0476
EndPage 208
ExternalDocumentID 15550916
10_3314_jjmm_45_203
article_jjmm1990_45_4_45_4_203_article_char_en
Genre English Abstract
Journal Article
Review
GroupedDBID ---
29N
2WC
53G
5GY
ABJNI
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
E3Z
EBS
EJD
F5P
JSF
OVT
RJT
RNS
XSB
123
36B
AAYXX
ABDBF
ACUHS
CITATION
EMB
EMOBN
ESX
KQ8
MK0
SV3
TUS
~8M
CGR
CUY
CVF
ECM
EIF
NPM
OK1
7X8
ID FETCH-LOGICAL-c320t-cc87016dc95bf5fd46215720feb0448c2a857fe159a770ac632f13f0e456f9b53
ISSN 0916-4804
IngestDate Fri Jul 11 08:25:34 EDT 2025
Wed Feb 19 01:37:59 EST 2025
Tue Jul 01 00:38:19 EDT 2025
Thu Apr 24 23:08:27 EDT 2025
Wed Sep 03 06:05:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4
Language English
Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c320t-cc87016dc95bf5fd46215720feb0448c2a857fe159a770ac632f13f0e456f9b53
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/jjmm1990/45/4/45_4_203/_article/-char/en
PMID 15550916
PQID 67087437
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_67087437
pubmed_primary_15550916
crossref_citationtrail_10_3314_jjmm_45_203
crossref_primary_10_3314_jjmm_45_203
jstage_primary_article_jjmm1990_45_4_45_4_203_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-00-00
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004-00-00
PublicationDecade 2000
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Nihon Ishinkin Gakkai zasshi
PublicationTitleAlternate Nippon Ishinkin Gakkai Zasshi
PublicationYear 2004
Publisher The Japanese Society for Medical Mycology
Publisher_xml – name: The Japanese Society for Medical Mycology
References 7) 田中秀治, 後藤英昭, 櫻井勝, 島崎修次:重症鈍的外傷患者における深在性真菌症発生のリスクと外傷重症度の検討. 日本外傷学会雑誌 13:216-222, 1999.
10) Solomkin JS, Flohr A, Simmons RL: Indications for therapy fungemia in postoperative patients. Arch Surg 117: 1272-1275, 1982.
2) Border JR: Trauma and sepsis, in Worth MH (eds): Principles and Practice of Trauma Care. Baltimore Williams & Wilkins, pp. 330-387, 1982.
5) 田中秀治, 古畑敏子, 後藤英昭, 櫻井勝, 島崎修次:救命救急センターにおける深在性真菌症の発生頻度の検討-真菌感染のリスクと疾病形態, 患者重症度との関係-. 真菌誌 40:135-142, 1999.
20) Obayashi T, Yoshida M, Mori T, et al.: Plasma (1-3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episords. Lancet 345: 17-20, 1995.
4) 田中秀治:重症患者において耐性菌を発生させないためのアプローチ. 平松啓一編. 耐性菌感染症の理論と実際. 医薬ジャーナル社, 東京 pp. 162-168, 1998.
9) Alexander JW, Boice ST, Babcock GF, et al.: The process or microbial translocation. Ann Surg 212: 496-512, 1990.
18) Aikawa N, Sumiyama Y, Kusachi S, et al.: Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan. J Infect Chemother 8: 237-241, 2002.
3) Vincent JL, Bihari DJ, Suter PM, et al.: The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 274: 639-644, 1995.
19) Dube MP, Heseltine PNR, Rinaldi MG, et al.: Fungemia and colonization with nystain-resistant Candida rugosa in a burn unit. Clin Infec Dis 18: 77-82, 1994.
13) Maejima K, Deitch EA, Berg R: Promotion by burn stress of the translocation of bacteria from the gastrointestinal tracts of mice. Arch Surg 119: 166-172, 1984.
11) Wey SB, Mori M, Pfaller MA, et al.: Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 149: 2349-2353, 1989.
15) Demajo WA, JG Guimond F, Rotstein C, et al.: Guideline for the management of nosocomial Candida infections in non-neutropenic intensive care patients. Canadian J Inf Dis 8 (Suppl. B): 3B-9B, 1997.
6) Dean DA, Burchard KW: Fungal Infection in surgical patients. Am J Surg 171: 374-382, 1996.
12) Berg RD, Garlington AW: Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23: 403-411, 1979.
1) Chitkara YK, Feierabend TC: Endogenous and exogenous infections with Pseudomonas aeruginosa in a bum unit. Int Surg 66: 237-240, 1981.
17) Wey SB, Motomi M, Pfaller MA, et al.: Hospitalacquired candidemia; The attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645, 1988.
14) British Society for Antimicrobial Chemotherapy Working Party: Management of deep Candida infection in surgical and intensive care unit patients. Intens Care Med 20: 522-528, 1994.
16) Pittet D, Monod M, Suter PM, et al.: Candida colonization and subsequent infections on critically ill surgical patients. Ann Surg 220: 751-758, 1994.
8) Maejima K, Deitch EA, Burg RD: Bacterial translocation from the gastrointestinal tract of rats receiving thermal injury. Infect Immun 43: 6-10, 1984.
References_xml – reference: 16) Pittet D, Monod M, Suter PM, et al.: Candida colonization and subsequent infections on critically ill surgical patients. Ann Surg 220: 751-758, 1994.
– reference: 17) Wey SB, Motomi M, Pfaller MA, et al.: Hospitalacquired candidemia; The attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645, 1988.
– reference: 20) Obayashi T, Yoshida M, Mori T, et al.: Plasma (1-3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episords. Lancet 345: 17-20, 1995.
– reference: 6) Dean DA, Burchard KW: Fungal Infection in surgical patients. Am J Surg 171: 374-382, 1996.
– reference: 9) Alexander JW, Boice ST, Babcock GF, et al.: The process or microbial translocation. Ann Surg 212: 496-512, 1990.
– reference: 12) Berg RD, Garlington AW: Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23: 403-411, 1979.
– reference: 18) Aikawa N, Sumiyama Y, Kusachi S, et al.: Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan. J Infect Chemother 8: 237-241, 2002.
– reference: 2) Border JR: Trauma and sepsis, in Worth MH (eds): Principles and Practice of Trauma Care. Baltimore Williams & Wilkins, pp. 330-387, 1982.
– reference: 19) Dube MP, Heseltine PNR, Rinaldi MG, et al.: Fungemia and colonization with nystain-resistant Candida rugosa in a burn unit. Clin Infec Dis 18: 77-82, 1994.
– reference: 1) Chitkara YK, Feierabend TC: Endogenous and exogenous infections with Pseudomonas aeruginosa in a bum unit. Int Surg 66: 237-240, 1981.
– reference: 4) 田中秀治:重症患者において耐性菌を発生させないためのアプローチ. 平松啓一編. 耐性菌感染症の理論と実際. 医薬ジャーナル社, 東京 pp. 162-168, 1998.
– reference: 7) 田中秀治, 後藤英昭, 櫻井勝, 島崎修次:重症鈍的外傷患者における深在性真菌症発生のリスクと外傷重症度の検討. 日本外傷学会雑誌 13:216-222, 1999.
– reference: 10) Solomkin JS, Flohr A, Simmons RL: Indications for therapy fungemia in postoperative patients. Arch Surg 117: 1272-1275, 1982.
– reference: 14) British Society for Antimicrobial Chemotherapy Working Party: Management of deep Candida infection in surgical and intensive care unit patients. Intens Care Med 20: 522-528, 1994.
– reference: 5) 田中秀治, 古畑敏子, 後藤英昭, 櫻井勝, 島崎修次:救命救急センターにおける深在性真菌症の発生頻度の検討-真菌感染のリスクと疾病形態, 患者重症度との関係-. 真菌誌 40:135-142, 1999.
– reference: 15) Demajo WA, JG Guimond F, Rotstein C, et al.: Guideline for the management of nosocomial Candida infections in non-neutropenic intensive care patients. Canadian J Inf Dis 8 (Suppl. B): 3B-9B, 1997.
– reference: 3) Vincent JL, Bihari DJ, Suter PM, et al.: The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 274: 639-644, 1995.
– reference: 13) Maejima K, Deitch EA, Berg R: Promotion by burn stress of the translocation of bacteria from the gastrointestinal tracts of mice. Arch Surg 119: 166-172, 1984.
– reference: 11) Wey SB, Mori M, Pfaller MA, et al.: Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 149: 2349-2353, 1989.
– reference: 8) Maejima K, Deitch EA, Burg RD: Bacterial translocation from the gastrointestinal tract of rats receiving thermal injury. Infect Immun 43: 6-10, 1984.
SSID ssj0032377
ssib002484596
ssib058493818
ssib002822044
ssib003115496
ssib050484239
ssib017628718
ssib023088339
ssib000959829
Score 1.3608485
SecondaryResourceType review_article
Snippet We retrospectively studied the efficacy of early presumptive therapy (EPT). Subjects and Method: Of the critically ill patients admitted from January 1998 to...
We retrospectively studied the efficacy of early presumptive therapy (EPT). Of the critically ill patients admitted from January 1998 to the end of December...
We retrospectively studied the efficacy of early presumptive therapy (EPT).UNLABELLEDWe retrospectively studied the efficacy of early presumptive therapy...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 203
SubjectTerms Antifungal Agents - administration & dosage
critical care medicine
deep fungal infection
Drug Administration Schedule
EPT
Female
Humans
Male
Mycoses - prevention & control
Retrospective Studies
Title Efficacy Study of Early Presumptive Therapy (EPT) for Deep Fungal Infection
URI https://www.jstage.jst.go.jp/article/jjmm1990/45/4/45_4_203/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/15550916
https://www.proquest.com/docview/67087437
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Nippon Ishinkin Gakkai Zasshi, 2004/10/30, Vol.45(4), pp.203-208
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1882-0476
  dateEnd: 20101231
  omitProxy: true
  ssIdentifier: ssj0032377
  issn: 0916-4804
  databaseCode: DIK
  dateStart: 19900101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdggMQL4puOLz_sAahSkthO3AceECp0TJqQ6KS9RXbirGnXtNraB_bXc2c7aTY2CXiJWucaJXe_nn93se8I2UsN9olLo0BHigdcCBOoQplASyV0ERYw59hqn4fJ-Ih_PxbH2y6OdnfJWg_yi2v3lfyPVWEM7Iq7ZP_Bsu1FYQA-g33hCBaG41_ZeIT1H7Bf-3lTGtrYesW4uBXMZFcFuQ1W9p3-6McEkwC4sLAwZtWHOe3E1txw67HqLlE9rKaAi31MUM2ruv9Nzeeq6l8A1Z5W22i_VnNLPsdVYabqbNOu5lna7kx2HChqm8YBcdcm-6ep_HCTceDdpGGUBFz6Ie8_XTlIjxPedYa2esEfTpqxiKOTni0WAy4GV6RAw6uFtRcwHWQzVwplu8jFn7pN7sSYh0EyvH_QpY1DGV8KK-OwQ2OwwhDflhmMYEKQnTkaojJswdz-XoCXwzqJ7XfJh0h0mhmfxcx2-Gy14_aB4nN-7Dyl7QDl7vsSCbo7gzjgxNwc4liqM3lIHvgYhX52gHtEbs3UY3LPdS399YQcNLCjFnZ0WVILO9qBHfWwo-8AdO8pQI4i5KiDHG0h95QcfR1NvowD35MjyFkcroM8BwcfJUU-FLoUZcET4IxpHJZGg4ZlHisp0tIASVZpGqo8YXEZsTI0QNTLoRbsGdmpl7V5QWjCijBRmpcshMtoIzkYRcYGfpEYLWWPfGiUlOW-YD32TTnNIHBF5Wao3IyLDJTbI3ut8MrVable7JPTdivk_7xWKAJqhoLcHUC-PY17IMHl9MjbxkgZ-GF8uaZqs9ycZ0kaSmDjaY88d7bb3oY3-u6NZ16S-25BGGb2XpGd9dnGvAauu9ZvLLB_Az33nL0
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+study+of+early+presumptive+therapy+%28EPT%29+for+deep+fungal+infection&rft.jtitle=Nihon+Ishinkin+Gakkai+zasshi&rft.au=Tanaka%2C+Hideharu&rft.au=Goto%2C+Hideaki&rft.au=Sakaki%2C+Seiki&rft.date=2004&rft.issn=0916-4804&rft.volume=45&rft.issue=4&rft.spage=203&rft_id=info:doi/10.3314%2Fjjmm.45.203&rft_id=info%3Apmid%2F15550916&rft.externalDocID=15550916
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-4804&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-4804&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-4804&client=summon